Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability

BACKGROUND: Paliperidone palmitate is a long-acting, second-generation antipsychotic (SGA) indicated for the treatment of acute exacerbations and maintenance treatment of adults with schizophrenia. This study addressed the response to paliperidone palmitate in Latin American patients with acute symp...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuropsychiatr Dis Treat
Главные авторы: Gattaz, Wagner F, Saracco-Alvarez, Ricardo, Daltio, Claudiane Salles, Van de Bilt, Martinus T, Ortegón, Jose Julian, Villaseñor-Bayardo, Sergio J, Louzã, Mario, Elkis, Helio, Soares, Bernardo, Cabrera Jaramillo, Patricia, Lawson, Fabio, Díaz-Galvis, Leonardo
Формат: Artigo
Язык:Inglês
Опубликовано: Dove 2020
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7490440/
https://ncbi.nlm.nih.gov/pubmed/32982245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S233537
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы